These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9322140

  • 21. Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial.
    Kobashigawa JA, Stevenson LW, Brownfield E, Moriguchi JD, Kawata N, Hamilton M, Minkely R, Drinkwater D, Laks H.
    J Heart Lung Transplant; 1993; 12(2):205-8. PubMed ID: 8476892
    [Abstract] [Full Text] [Related]

  • 22. Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy.
    DeNofrio D, Rosengard BR, Reynolds C, Acker MA, Rook AH, Loh E.
    J Heart Lung Transplant; 1998 Oct; 17(10):1036-7. PubMed ID: 9811415
    [No Abstract] [Full Text] [Related]

  • 23. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [Abstract] [Full Text] [Related]

  • 24. Some aspects of changed histopathologic appearance of acute rejection in cardiac allografts after prophylactic application of OKT3.
    Kemnitz J, Cremer J, Schaefers HJ, Restrepo-Specht I, Haverich A, Uysal A, Heublein B, Wirth S.
    J Heart Lung Transplant; 1991 Jun; 10(3):366-72. PubMed ID: 1906746
    [Abstract] [Full Text] [Related]

  • 25. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K, John R, Burke E, Schuster M, Rogers TB, Suciu-Foca N, Mancini D, Itescu S.
    Circulation; 2005 Oct 18; 112(16):2468-76. PubMed ID: 16230499
    [Abstract] [Full Text] [Related]

  • 26. Grade 2 cellular heart rejection: does it exist?: Yes!
    Kemnitz J.
    J Heart Lung Transplant; 1995 Oct 18; 14(4):800-1. PubMed ID: 7578197
    [No Abstract] [Full Text] [Related]

  • 27. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients.
    Toyoda M, Galfayan K, Wachs K, Czer L, Jordan SC.
    Clin Transplant; 1995 Dec 18; 9(6):472-80. PubMed ID: 8645891
    [Abstract] [Full Text] [Related]

  • 28. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L, García-Palomar C, Martínez-Dolz L, Chamorro C, Moro J, Zorio E, Arnau MA, Rueda J, Osa A, Cardo ML.
    Transplant Proc; 2005 Nov 18; 37(9):4024-7. PubMed ID: 16386616
    [Abstract] [Full Text] [Related]

  • 29. Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin.
    Zhang R, Haverich A, Strüber M, Simon A, Bara C.
    J Heart Lung Transplant; 2008 Jun 18; 27(6):603-9. PubMed ID: 18503958
    [Abstract] [Full Text] [Related]

  • 30. Risk/benefit ratio of perioperative OKT3 in cardiac transplantation.
    Johnson MR, Mullen GM, O'Sullivan EJ, Liao Y, Heroux AL, Kao W, Pifarre R, Costanzo-Nordin MR.
    Transplant Proc; 1993 Feb 18; 25(1 Pt 2):1149-51. PubMed ID: 8442068
    [Abstract] [Full Text] [Related]

  • 31. Proton magnetic resonance spectroscopy of blood plasma in heart transplant recipients treated with cyclosporine: an early prognosis test of long-term graft tolerance.
    Le Floch M, Ramee MP, LeLong B, Leray G, Kerbaol M, de Certaines JD.
    J Heart Lung Transplant; 1997 Apr 18; 16(4):381-6. PubMed ID: 9154946
    [Abstract] [Full Text] [Related]

  • 32. The use of OKT3 for stubborn heart allograft rejection: an advance in clinical immunotherapy?
    Sweeney MS, Sinnott JT, Cullison JP, Weinstein SS.
    J Heart Transplant; 1987 Apr 18; 6(6):324-8. PubMed ID: 3320302
    [Abstract] [Full Text] [Related]

  • 33. Early screening for antibody-mediated rejection in heart transplant recipients.
    Kfoury AG, Hammond ME, Snow GL, Stehlik J, Reid BB, Long JW, Gilbert EM, Bader FM, Bull DA, Renlund DG.
    J Heart Lung Transplant; 2007 Dec 18; 26(12):1264-9. PubMed ID: 18096477
    [Abstract] [Full Text] [Related]

  • 34. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM, Glanemann M, Guckelberger O, Klupp J, Neumann U, Machens C, Lohmann R, Knoop M, Lobeck H, Schlag H, Keck H, Settmacher U, Bechstein WO, Neuhaus PJ.
    Clin Transplant; 1998 Aug 18; 12(4):303-12. PubMed ID: 9686324
    [Abstract] [Full Text] [Related]

  • 35. Treatment of humoral rejection after heart transplantation.
    Grauhan O, Müller J, v Baeyer H, Volk HD, Fietze E, Cohnert T, Meyer R, Pfitzmann R, Mansfeld H, Siniawski H, Warnecke H, Hetzer R.
    J Heart Lung Transplant; 1998 Dec 18; 17(12):1184-94. PubMed ID: 9883759
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K, John R, Beniaminovitz A, Burke EM, Suciu-Foca N, Mancini DM, Edwards NM, Itescu S.
    Transplantation; 2003 Mar 27; 75(6):781-7. PubMed ID: 12660501
    [Abstract] [Full Text] [Related]

  • 37. Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines.
    Abbs IC, Clark M, Waldmann H, Chatenoud L, Koffman CG, Sacks SH.
    Ther Immunol; 1994 Dec 27; 1(6):325-31. PubMed ID: 7584508
    [Abstract] [Full Text] [Related]

  • 38. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 27; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 39. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
    Higgins R, Kirklin JK, Brown RN, Rayburn BK, Wagoner L, Oren R, Miller L, Flattery M, Bourge RC, Cardiac Transplant Research Database (CTRD).
    J Heart Lung Transplant; 2005 Apr 27; 24(4):392-400. PubMed ID: 15797738
    [Abstract] [Full Text] [Related]

  • 40. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.